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ABSTRACT
DNA methylation is an important epigenetic modi-
fication in many species that is critical for devel-
opment, and implicated in ageing and many com-
plex diseases, such as cancer. Many cost-effective
genome-wide analyses of DNA modifications rely on
restriction enzymes capable of digesting genomic
DNA at defined sequence motifs. There are hundreds
of restriction enzyme families but few are used to
date, because no tool is available for the systematic
evaluation of restriction enzyme combinations that
can enrich for certain sites of interest in a genome.
Herein, we present customised Reduced Represen-
tation Bisulfite Sequencing (cuRRBS), a novel and
easy-to-use computational method that solves this
problem. By computing the optimal enzymatic di-
gestions and size selection steps required, cuRRBS
generalises the traditional MspI-based Reduced Rep-
resentation Bisulfite Sequencing (RRBS) protocol
to all restriction enzyme combinations. In addition,
cuRRBS estimates the fold-reduction in sequencing
costs and provides a robustness value for the per-
sonalised RRBS protocol, allowing users to tailor
the protocol to their experimental needs. Moreover,
we show in silico that cuRRBS-defined restriction
enzymes consistently out-perform MspI digestion in
many biological systems, considering both CpG and
CHG contexts. Finally, we have validated the accu-
racy of cuRRBS predictions for single and double en-
zyme digestions using two independent experimen-
tal datasets.
BACKGROUND
With the advent of next-generation sequencing (NGS) sci-
entists are studying the biology of life at unprecedented res-
olution (1). Unfortunately, owing to the large size of many
commonly studied genomes (human, mouse and tobacco
plant for example are all >2.5 Gbp in size) (2–4), it is of-
ten still prohibitively expensive to conduct whole genome
sequencing at high coverage. This creates a trade-off that
negatively impacts the number of replicates that can be in-
cluded and, therefore, it challenges the statistical power and
the reproducibility of the studies (5,6). This is true in partic-
ular for DNA methylation, where differentially methylated
regions (DMRs) are typically called by identifying changes
as small as 10% and where 70–80% of the reads of Whole
Genome Bisulfite Sequencing (WGBS) methods contain lit-
tle to no relevant information on the DNAmethylation sta-
tus (7).
To address these cost inefficiencies, many methods have
been developed to reduce the number of fragments that need
to be sequenced for a given biological system orWGBS val-
idation experiment (8–25). These methods can be broadly
split into those that positively select for genomic fragments
of interest and those that deplete for fragments that are
not of interest. Positive selection-based methods involve
the sites of interest being enriched from the background.
This usually occurs through pull-down of these sites via
an antibody (e.g. anti-5mC antibody), a recombinant bind-
ing protein (e.g. methyl-CpG-binding domains (MBD)),
RNA baits for the sites of interest, array-based approaches
(e.g. EPIC array in human) or PCR-based approaches (26).
These methods have many limitations, including enrich-
ment biases, complex protocols and difficulties in quantifi-
cation (27).
Current evidence shows that depletion-based methods
do not have enrichment biases, tend to be simpler and
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are more readily quantifiable (26,27). The most common
depletion-based approaches use restriction enzymes to ex-
ploit the fact that the nucleotide composition in a given
genome is non-random (28) and that the fragment lengths
produced from a given digestion will thus reflect this. In
the case of 5-methylcytosine (5mC), the most common
depletion-based method is Reduced Representation Bisul-
fite Sequencing (RRBS) using the methylation-insensitive
restriction enzyme MspI (with the recognition sequence
C|CGG), although enzymes such as BglII, XmaI and TaqI
have also been used (29–31). RRBS has proven extremely
useful for cost-effective, global studies of DNAmethylation
(10,32,33), capturing around 10%ofCpG sites withinmam-
malian genomes but with up to a 30-fold reduction in the
number of fragments sequenced in comparison to WGBS
(34).
Whilst restriction enzyme-based approaches are versa-
tile, simple and cost-effective, the utility of the MspI-based
RRBS approach is limited to a specific subset of CpG sites
in the genome, mainly found within CpG islands and pro-
moters (32). To allow researchers to optimise the protocol
used for their specific experiment, we have developed a new
computational method called customised Reduced Repre-
sentation Bisulfite Sequencing (cuRRBS). cuRRBS gener-
alises the problem of genomic enrichment with restriction
enzymes by allowing the user to define both the genome and
the particular sites of interest, before outputting the optimal
enzyme combinations and size ranges to target these sites. In
addition, cuRRBS provides the user with a variety of met-
rics to compare the various suggested protocols, including
an estimate of the fold-reduction in sequencing costs com-
pared toWGBS and a robustness value to assess the impact
of experimental error in the size selection step.
Here, we have tested the enrichment ability of cuRRBS
in several biological systems, with sites in both CpG and
CHG contexts and multiple species, to showcase the gener-
alisability and utility of the software (35–41). In addition,
we take advantage of two recently published independent
RRBS datasets to demonstrate the accuracy of the software
predictions in both single and double enzyme experimental
settings (30,31).
We hope that cuRRBSwill be useful both as a tool for de-
signing cost-effective, genome-wide studies in the future but
also for validating previous results from whole genome ap-
proaches in a simple, cheap and timely fashion, something
that at present is not possible.
MATERIALS AND METHODS
Restriction enzymes annotation
All the information regarding the commercially-available
restriction enzymes that are used by cuRRBS was ex-
tracted from REBASE (42,43). Restriction enzymes were
grouped in isoschizomer families (i.e. enzymes that recog-
nise the same sequence and generate identical fragment
length distributions) and each enzyme was manually an-
notated for different types of methylation-sensitivity (CpG,
CHG, CHH). Only isoschizomer families that contained at
least one methylation-insensitive enzyme were considered
for the examples described in this manuscript.
Genome assemblies and genomic annotation
All the analyses presented here were performed in the fol-
lowing genome assemblies:Homo sapiens (hg38),Mus mus-
culus (mm10) andArabidopsis thaliana (TAIR10). Scaffolds
not assembled into the main chromosomes were discarded.
Genomic annotation for the human genome (hg38) was ob-
tained from GENCODE (v25, basic gene annotation) (44),
with the exception of CpG islands (CGIs), which were ex-
tracted from the UCSC Genome Browser (45). GC content
and CpG content were calculated, around each restriction
enzyme cleavage site, taking windows of ±25 bp and ±500
bp respectively. For each enzyme, the mean of all cleavage
sites was calculated to obtain the mean GC content and the
mean CpG content. Intragenic regions were defined as those
regions within ±2.5 kb of a protein-coding gene, whilst the
rest of the genome was considered to be intergenic. CpG
shores were defined as regions 0 to 2 kb away from CGIs in
both directions and CpG shelves as regions 2 to 4 kb away
from CGIs in both directions (46). Promoters were defined
as encompassing a 3 kb region (2.5 kb upstream and 0.5 kb
downstream of the TSS) relative to the TSS of all protein-
coding transcripts in GENCODE, similar to the strategy
used in Taher et al. (47). Genomic annotation for the CGIs
in the mouse genome (mm10) was also obtained from the
UCSCGenomeBrowser (45). All annotations were handled
using the pybedtools library (48,49).
Performing in silico digestions of a given genome
We used the Restriction package from Biopython v1.68 to
digest the different genomes with the appropriate restric-
tion enzymes in silico (50). Only the first member of a
given isoschizomer family (which contained at least one
methylation-insensitive enzyme) was processed to avoid re-
dundant computations. The output of the in silico diges-
tions was stored (pre-computed files) and subsequently
read by cuRRBS when needed to reduce the computa-
tional time (see ‘cuRRBS heuristics and computational ef-
ficiency’). When assessing enzyme combinations, the infor-
mation from the appropriate individual pre-computed files
(i.e. the genomic coordinates where the enzyme theoretically
cuts) were combined by the software to compute all the nec-
essary variables.
cuRRBS’ enzyme flexibility
To ensure the user has full control over the enzymes that
cuRRBS will use to derive the desired enrichments, one of
the inputs given to cuRRBS is an enzyme annotation file.
This file contains the desired isoschizomer families that the
user wishes to be tested by cuRRBS. In the GitHub reposi-
tory we have already defined enzyme annotation files for en-
zymes that are methylation-insensitive in a CG context and
in CG, CHG and CHH contexts (51). However, it is also
possible for the user to define a personalised set of enzymes
by providing a self-generated annotation file. This can be
useful, for instance, to reduce the chance of any star activ-
ity in the reported cuRRBS protocols.
In addition, the output file from cuRRBS contains, by de-
fault, 30 cuRRBS protocols that would enrich for the user’s
sites of interest. Therefore, the user can determine which
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enzyme combination and size range would be the simplest
and most appropriate for the given application. This pro-
vides the user with the opportunity to consider experimen-
tal factors that may complicate the protocol, such as buffer
compatibility and whether consecutive digestions would be
required.
Calculating cuRRBS main variables
cuRRBS makes use of several variables in order to find the
best enzyme combination and size range which enriches for
a certain set of genomic sites defined by the user (see ‘cuR-
RBS overview’). For a given enzyme (combination) and size
range, the Enrichment Value (EV) can be calculated as:
EV = −log10
(
Score
NF
· n
max Score
)
Here, NF is the number of genomic fragments that will the-
oretically be sequenced (i.e. those whose lengths after the in
silico digestion are within the size range); n is the total num-
ber of sites of interest;max Score is the Score obtained if all
the sites of interest were sequenced and:
Score =
n∑
i=1
wi · γi
where wi is the weight of the ith site of interest and γ i is 1 if
the ith site would be theoretically sequenced (i.e. present in
a size selected fragment and ≤ read length base pairs away
from one of the ends of the fragment) and 0 otherwise. Since
the objective of cuRRBS is to maximize the Score while
minimizing the NF, the best results will be obtained when
EV is minimized.
cuRRBS output also contains other variables that may
be of interest to the user (see ‘cuRRBS overview’). TheCost
Reduction Factor (CRF) for a given cuRRBS protocol can
be calculated as:
CRF = NFref
NF
= g/r
NF
where NFref is the estimated number of fragments that
would be sequenced in a Whole Genome Bisulfite Sequenc-
ing (WGBS) experiment, that can be roughly calculated as
the genome size (g) divided by the read length (r).
Furthermore, the robustness (R) of a given enzyme (com-
bination) is calculated as:
R= e−θ
with
θ =
∑
x∈{a−δ,a,a+δ}
∑
y∈{b−δ,b,b+δ}
∣∣EVx,y − EVa,b∣∣
EVa,b
where EVa,b is the EV for the optimal size range (a: lower
limit in size range, b: breadth) and δ is the experimental er-
ror (in bp) that is assumed during the size selection step. The
robustness will take values in the interval (0,1], with higher
values identifying robust cuRRBS protocols.
Flexible user-defined cuRRBS parameters
cuRRBS contains a number of user-defined parameters to
ensure the greatest possible flexibility and ease of use. A ta-
ble of these parameters is provided to highlight the versatil-
ity that the user has and why such versatility is useful (Table
1).
cuRRBS heuristics and computational efficiency
cuRRBS employs several strategies to reduce the computa-
tional time needed in each run:
1. Restriction enzymes are grouped in isoschizomer fami-
lies. Since isoschizomers generate the same genomic di-
gestions, only one member of each family needs to be
processed.
2. In silico digestions are read from pre-computed files.
Digesting the genomes would be a limiting factor in
the cuRRBS pipeline. The user can download the pre-
computed files (51) and the information that they con-
tain is read every time that an enzyme needs to be as-
sessed.
3. The number of size ranges that are sampled isminimised.
Since the experimental size selection step is generally im-
perfect, size ranges are sampled with a sliding window
whose ‘resolution’ is equivalent to the experimental er-
ror specified by the user.
4. Parallelization. cuRRBS can use several cores to de-
crease the CPU time.
Moreover, we have observed that, in many enzyme com-
binations, one of the enzymes is providing most of the en-
richment for the sites of interest, while the second one com-
plements the targeting. Therefore, it would be possible to
implement a ‘heuristic’ mode, where only those enzymes
that perform well individually are used as ‘seeds’ to con-
struct combinations (as opposed to the current implemen-
tation, where all the enzyme combinations are checked ex-
haustively). This could further reduce the computational
time, especially if combinations of more than two enzymes
were being evaluated.
The CPU time required by cuRRBS depends on several
parameters, including the number of enzymes checked, the
experimental error, the number of sites of interest or the
genome size (Supplementary Figure S1A–D). The RAM
used will be approximately equal to the size of the pre-
computed files that are read by the software. A standard
cuRRBS run (e.g. for a few thousand sites of interest in the
human genome, checking 128 CpG methylation-insensitive
isoschizomer families) takes∼0.5–1 h and uses around 4GB
RAM, which allows the user to easily run it on a dual-core
laptop or desktop computer.
Obtaining the sites of interest for different biological systems
We have tested in silico the ability of cuRRBS to enrich for
the sites of interest in a selection of different biological sys-
tems where DNA methylation has an important functional
role. In some of these systems, described below, previous
analysis was performed in order to obtain the genomic co-
ordinates for the sites:
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Table 1. Flexible user-defined cuRRBS parameters
cuRRBS parameter (abbrev.) Significance Default Range
Enzymes to check (-e) Defines the enzymes (isoschizomer families) that cuRRBS will
look at
- -
Annotation for the sites of interest (-a) Allows identification and weighting of the sites of interest - -
Read length (-r) Defines the positions in the theoretical fragments that can be ‘seen’
after sequencing
- 30–300
Adapters size (-s) Ensures correct experimental size selection - -
C Score constant (-c) Sets the minimum acceptable Score - 0–1
Genome size (-g) Needed to calculate the CRF - -
C NF/1000 constant (-k) Sets the minimum acceptable CRF 0.2 0–1
Experimental error (-d) Sets the assumed experimental error (δ) 20 5–500
Size range breadth (-b) Constrains the breadth of the size range 980 -
Output size (-t) Defines the number of cuRRBS protocols the user can compare 30 -
Site IDs (-i) Enables the identification of the recovered sites of interest No -
This table details the flexible user-defined parameters that cuRRBS will accept as arguments. The cuRRBS parameter full name and command-line abbre-
viation (in brackets) are provided alongside a simplified description of the significance of these arguments to the user. Where applicable, the defaults and
ranges are also detailed.
1. Exon-intron boundaries in human. Exons and introns
were obtained from protein-coding genes using GEN-
CODE annotation data. Those CpG sites that were
found within ± 5 bp of a canonical splice site (5′-GT,
3′-AG) were selected.
2. Epigenetic clock in human. These sites were obtained
fromHorvath (37). Briefly, these sitesmake up an elastic-
net regression model that is able to predict chronological
and biological age in humans. These sites were lifted over
to hg38 for the analysis conducted in this paper (52).
3. Canonical and placental imprints in human. These loci
were obtained from Hanna et al., 2016 (35). These sites
were lifted over to hg38 and the CpG sites were then ex-
tracted for the analysis conducted in this paper (52).
4. CTCF binding sites in human. We obtained the CpG
sites that overlap with in vivo CTCF binding sites. Peaks
from sites that seem to be affected by methylation (up-
regulated, reactivated) were kindly provided by Mau-
rano (39). We scanned the peaks for high-scoring motifs
according to the CTCF JASPARmodel (53). Finally, we
extracted those CpGs that were found in positions 5 and
15 of the motif, whose methylation status is supposed to
influence the binding of the transcription factor (39).
5. Induced pluripotent stem cell (iPSC) demethylated and
maintained sites in mouse. These were obtained as de-
scribed previously (36), with an additional filter for mag-
nitude of methylation change. In brief, a background
model was obtained by calculating the global mean for
the ending methylation value for each starting methy-
lation value, comparing mouse embryonic fibroblasts
(MEFs) to iPSCs. Afterwards, a binomial test was used
on individual probes for their ending methylation mea-
sured against the mean for their starting methylation, to
obtain p-value < 0.05 differentially methylated regions
(DMRs). Adjusted p-values were calculated using a pair-
wise t-test with a Benjamini–Hochberg correction and
only probes accounting formore than 50% loss ofmethy-
lation relative to the genome average loss (from MEFs
to iPSCs, commonly located at super-enhancer regions)
or more than 50% gain in methylation relative to the
genome average loss (from MEFs to iPSCs, commonly
located at intracisternal A-particles) were used in this
analysis.
6. NRF1 binding sites inmouse.We obtained theCpG sites
that overlap with in vivo NRF1 binding sites in mouse.
ChIP-seq data was processed as described in the original
publication (41), where peaks were called using Peakzilla
(54). We took as our final set of peaks the overlap be-
tween the two TKO replicates. Next, we scanned the
peaks for high-scoring motifs according to the NRF1
JASPAR model (53). Finally, we extracted those CpGs
that were found in positions 2 and 8 of the motif, whose
methylation status is supposed to influence the binding
of the transcription factor (41).
7. CHG sites in Arabidopsis thaliana. Non-CpG DMRs
arising from the epigenomic diversity betweenArabidop-
sis thaliana accessions were obtained from Kawakatsu
et al. (38). The coordinates for C sites in non-CpG con-
text were extracted.
In all the cases the sites were equally weighted (wi =
1), with the exception of the human epigenetic clock sys-
tem, where the sites were assigned the absolute value of the
weights in the linear model (37).
All the site annotation files are provided as Supplemen-
tary Tables S1–S9.
Running cuRRBS for different in silico systems
cuRRBS was run in the different systems described above
using the default parameters (k = 0.2, d = 20, b = 980, t =
30), for a read length (r) of 75 bp and a Score threshold (c)
of 0.25. In the mouse and human examples we considered
128 isoschizomer families that contained enzymes that were
not sensitive to CpG methylation. In the case of Arabidop-
sis thalianawe used 28 isoschizomer families that contained
enzymes that were not sensitive to 5mC in any context (CG,
CHG, CHH).
Mapping of RRBS samples
XmaI-RRBS data generated on the Ion Torrent plat-
form (30) and MspI&TaqI-RRBS data generated on
the Illumina HiSeq platform (31) were quality-trimmed
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using Trim Galore (www.bioinformatics.babraham.ac.uk/
projects/trim galore/) and had base pairs removed from the
3′ end to avoid including filled-in nucleotides with artifi-
cial methylation states (the filled-in XmaI, MspI and TaqI
cut sites include the nucleotide sequence CCGG, CG and
CG respectively). The data was then mapped to the hu-
man genome (forXmaI data, parameters: –non directional)
or the mouse genome (for MspI&TaqI data, parameters:
–directional) using Bismark (0.18.0) (55). In each of the
two cases data from different experiments or replicates was
merged into the same FASTQ file prior to quality trimming.
Estimating cuRRBS’ sensitivity and specificity
We assessed the performance of cuRRBS predictions in two
independent experimental datasets (30,31) (see ‘Experimen-
tal validation of cuRRBS’ in Results and discussion). We
ran cuRRBS fixing the theoretical size ranges tested to the
ones reported in the publications (30,31) and we used as our
sites of interest the CpGs that overlapped with CpG islands
(CGI-CpGs) in the human (30) and themouse genomes (31)
respectively. From the cuRRBS output files, we recovered
the IDs of the sites that should be theoretically sequenced.
Moreover, using the experimental RRBS data (30,31), we
could obtain the IDs of the sites that were actually se-
quenced (filtered by a given depth of coverage threshold).
Afterwards, we calculated the following variables for each
one of the datasets:
1. True positives (TP): number of CGI-CpGs that cuRRBS
predicted to be sequenced and were indeed found in the
RRBS data.
2. True negatives (TN): number of CGI-CpGs that cuR-
RBS predicted to be absent and were not found in the
RRBS data.
3. False positives (FP): number of CGI-CpGs that cuR-
RBS predicted to be sequenced but were not found in
the RRBS data.
4. False negatives (FN): number of CGI-CpGs that cuR-
RBS predicted to be absent but were found in the RRBS
data.
Finally, we estimated the sensitivity and specificity, for a
given dataset, as follows:
Sensi tivi ty = TP
TP + FN · 100
Speci f ici ty = TN
FP + TN · 100
RESULTS AND DISCUSSION
Restriction enzyme digestion as a tool for genomic enrich-
ment
Restriction enzymes represent an incredibly effective tool
for the enrichment of certain sites of interest in a genome.
This is possible due to the wide variety of motifs that
commercially-available restriction enzymes can recognise
(Supplementary Figure S2A andB) combinedwith the non-
random nature of the genome composition itself. Supple-
mentary Figure S2A and B highlight that this motif diver-
sity is driven both by the sequence composition (GC con-
tent) and the length of the recognition sequence. Thus, dif-
ferent restriction enzymes will generate different fragment
length distributions, dependent upon how frequently their
recognition site is present in a given genome (Figure 1A,
Supplementary Figure S2C).
In DNA methylation studies the most common applica-
tion is the use of MspI (cutting at C|CGG) in RRBS (Re-
duced Representation Bisulfite Sequencing), which is used
to enrich for CG dinucleotides (CpGs) contained in pro-
moters andCpG islands (32) (Figure 1B).However, inmany
cases, MspI is by no means the most effective restriction
enzyme that could be used. For instance, MspI would be
a poor restriction enzyme to choose for the enrichment
of CpGs found in intergenic regions or non-coding RNA
genes, which would be far better enriched for using BsmI
or MfeI respectively (Figure 1C). In fact, it turns out that
across many genomic features MspI is rarely the most op-
timal methylation-insensitive restriction enzyme (Supple-
mentary Figure S2D).
Previous studies have tested the potential of other re-
striction enzymes and enzyme combinations to expand the
range of CpG sites that can be targeted in a genome (8–
11,28,30,56,57). However, to our knowledge, there is cur-
rently no computational method that systematically ex-
plores the capacity of all commercially-available restriction
enzymes to generate ‘personalised’ reduced-representations
of the genome whilst minimising the experimental cost
(Supplementary Figure S2E).
cuRRBS overview
We have developed a novel computational method (cuR-
RBS) that determines the optimal combination of restric-
tion enzymes and size range to enrich for any given set of
sites of interest in any genome. In other words, by modify-
ing two of the steps in the original RRBS protocol (Figure
2A), cuRRBS generalises RRBS.
The software takes as input the genomic coordinates that
the user wants to target (Figure 2B, Supplementary Figure
S3A). Afterwards, cuRRBS assesses in silico the potential
of all single enzymes and double-enzyme combinations to
enrich for the sites of interest using the following two key
variables (see Materials and Methods):
1. NF, which reflects the theoretical number of fragments
that will be sequenced after the size selection step. As-
suming that the sequencing cost is proportional to NF,
cuRRBS attempts to minimise this value.
2. Score, which reflects the theoretical number of sites of in-
terest that will be sequenced after the size selection step.
cuRRBS attempts to maximise this value.
TheNF and Score variables are positively correlated with
one another, such that the more genomic fragments se-
quenced, the more sites of interest are likely to be contained
within the reduced representation (Figure 2C, Supplemen-
tary Figure S3B). However, this relationship disappears at
higher NF values, where the Score variable becomes satu-
rated such that any additional fragments sequenced will re-
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Figure 1. Restriction enzyme digestion as a tool for genomic enrichment. (A) Heatmap showing the fragment length distributions generated by different
restriction enzymes in the human genome (hg38). Each column represents the distribution for an isoschizomer family of restriction enzymes that contains
at least one member which is methylation-insensitive in a CpG context. The distributions are binned in size ranges of 200 bp, ordered as they would appear
in an electrophoretic gel. Additional row annotations on top of the heatmap contain information regarding the total number of fragments (in red) and the
median fragment length (in blue) produced by each in silico digestion, together with the GC content of the recognition motif in the isoschizomer family
(in green). Legend is displayed on the right hand side. (B) Scatterplot showing the percentage of cleavage sites from different restriction enzymes that
overlaps with CpG islands (X-axis) and promoters (Y-axis) in the human genome (hg38). The size of the circles represents the total number of cleavage
sites generated by each enzyme. The enzymes MspI and BssAI are highlighted in red and blue respectively. Legend is displayed on the right hand side. (C)
Scatterplot showing the percentage of cleavage sites from different restriction enzymes that overlap with intergenic regions (X-axis) and non-coding RNA
genes (Y-axis) in the human genome (hg38). The size of the circles represent the total number of cleavage sites generated by each enzyme. The enzyme
MspI is highlighted in red. The enzymes BsmI and MfeI are both highlighted in blue. Legend is displayed on the right hand side.
sult in a reduction in the overall enrichment of the sites of
interest. This Score saturation at high NF is mainly due to
additional sites of interest being buried within long frag-
ments that will not be sequenced due to limitations in the
read length (cuRRBS parameter –r, see Table 1). For a given
enzyme or enzyme combination, theNF and the Score vari-
ables depend on the size range chosen, since only the ge-
nomic fragments within the size range will be present in the
reduced representation of the genome.
cuRRBS requires that the user sets thresholds for the
maximumNF (i.e. minimumCRF) andminimumScore that
would be acceptable for a given application (Figure 2B, Sup-
plementary Figure S3A). These thresholds allow cuRRBS to
search through all possible size ranges for a given enzyme or
enzyme combination and to find the one that minimises the
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Figure 2. cuRRBS overview. (A) Outline of an RRBS protocol. Highlighted are the two steps that would be modified according to the output produced
by cuRRBS (i.e. the restriction enzymes used for the genomic digestion and the size selection). Legend is displayed on the bottom left. (B) Schematic
of cuRRBS. Highlighted are the two main inputs required for the software and the two thresholds that the user has to define (red and purple tags). The
default output for cuRRBS is a table containing the top hits (restriction enzyme combination and size range) along with additional information that might
be useful to the user (such as Cost Reduction Factor and robustness). (C) Scatterplot showing the trade-off between the number of fragments (NF) and
the Score for the best enzyme combination (BsaWI & BssAI) that targets the CpGs present in the human placental-specific imprinted regions (35). NF is
divided by 1000 for visualization purposes. Each point represents a different size range. Shown in dark blue and grey are the size ranges that would and
would not pass filtering respectively. Shown in orange is the optimal size range in the filtered search space. The dotted lines depict the thresholds that need
to be specified by the user (red: maximum NF; purple: minimum percentage of the maximum Score). In this mock example we specified an NF threshold
of 150 000 fragments and a Score threshold of 25% of the maximum Score. Legend is displayed below the plot title. (D) Contour plot that depicts how
the robustness (R) variable is calculated for the optimal enzyme combination (BsaWI & BssAI; size range: 60–540 bp) that targets the CpGs present in the
human placental-specific imprinted regions (35). Enrichment values (EVs) are calculated for all possible size ranges in order to create an ‘EV landscape’.
In this landscape, cuRRBS finds the size range with the lowest EV that still satisfies the thresholds (asterisk in green). Afterwards, cuRRBS samples EVs
around the optimum (asterisks in black). The points that are sampled depend on the experimental error (in this case, δ = 20 bp). A high robustness value
means that the sampled EVs do not change a lot when compared to the optimum, which implies that cuRRBS prediction will not be greatly affected by
experimental errors during the size selection step.
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Enrichment Value (EV), a variable that combines both NF
and Score into a single number (see Materials and Meth-
ods). cuRRBS repeats this procedure for every single en-
zyme and enzyme combination and reports those with the
best hits (i.e. those with the lowest EVs) (Supplementary
Figure S3A).
The output file contains the best scoring enzymes with
their correspondent size ranges and some other useful vari-
ables for each one of the hits, such as (see Materials and
Methods):
1. Cost Reduction Factor (CRF). This estimates the theoret-
ical fold-reduction in sequencing costs for the cuRRBS
protocol when compared toWhole Genome Bisulfite Se-
quencing (WGBS).
2. Robustness (R). This assesses how much the cuRRBS
prediction varies if a slightly different size range is used
(Figure 2D). The results for robust enzymes will not be
greatly affected as a consequence of experimental error
during the size selection step. This will help the user to
make an informed decision on which enzyme combina-
tion to choose for the system of interest (Supplementary
Figure S3C).
Running cuRRBS in different biological systems
cuRRBS provides a way to effectively interrogate DNA
methylation in any biological system for which the reference
genome is available. Besides reducing the cost for organ-
isms currently under intensive study (e.g. human, mouse),
cuRRBS opens the door to the cost-effective study of
DNA methylation in species with large genomes or where
DNA methylation in non-CpG contexts is common, such
as plants (58), which currently lack an MspI-based RRBS
protocol, owing to the enzyme’s CHGmethylation sensitiv-
ity (59).
We decided to test the ability of cuRRBS to enrich for ge-
nomic sites that have important functional roles in different
systems. Some of the systems that we tested in silico include
genomic regions whosemethylation status is important dur-
ing cellular reprogramming (36), an epigenetic clock (37),
transcription factor binding sites that are affected by DNA
methylation (39,41), imprinted loci (35), CpGs found in the
exon-intron boundaries and CHG sites that are differen-
tially methylated between different arabidopsis accessions
(38) (Supplementary Figure S4). For these in silico systems
we chose to run the software with the threshold set to 25%
of the maximum Score.
In all cases, cuRRBS is able to dramatically reduce the
cost associated with the sequencing by several orders of
magnitude compared to WGBS, which is assessed using
the Cost Reduction Factor (CRF) (Supplementary Figure
S5). In addition, for cases where a comparison to MspI-
based RRBS could be made, cuRRBS is able to improve
theCRF, again, by orders of magnitude. As an example, for
the placental-specific imprints, the sequencing costs are re-
duced by approximately 400-fold when compared toWGBS
and by 12.5-fold when compared to the traditional MspI-
based RRBS.
Furthermore, we have also observed that many of the top
hits reported by cuRRBS are digestions of two restriction
enzymes (Supplementary Figure S4), highlighting the com-
binatorial power of restriction enzymes to produce optimal
reduced representations of the genome (28). Excitingly, we
are able to show that using cuRRBS it is possible to assay a
far larger number of target sites, in a far simpler experimen-
tal design thanwould normally be achieved using amplicon-
based bisulfite sequencing.
Experimental validation of cuRRBS
To assess in an unbiased manner how well predictions from
cuRRBS perform in an experimental setting, we employed
two independent non-canonical RRBS datasets: one gen-
erated from a single enzyme (XmaI) and the other from a
combination of two restriction enzymes (MspI and TaqI)
(30,31). By evaluating the predictive power of cuRRBS in
these two datasets, we were able to observe cuRRBS’ per-
formance in both single and double enzyme contexts and
across different genomes.
To test the accuracy of cuRRBS predictions in the con-
text of a single enzyme digestion, we utilised the non-
canonical RRBS dataset generated from human DNA us-
ing the restriction enzyme XmaI (30). This dataset was pre-
viously used to show that XmaI could enrich for CpG is-
lands (CGIs), while reducing the overall sequencing cost rel-
ative to MspI, making the protocol more cost-effective. To
validate cuRRBS using this system, we therefore chose to
enrich for all CpG sites that overlapped with a CGI (CGI-
CpGs) in the human genome using a predetermined the-
oretical size range equivalent to the ‘reproducible library
fragment lengths’ reported in (30) (i.e. 90–185 bp). cuR-
RBS predicted with high accuracy the CpG sites that were
observed in the experimental XmaI-RRBS dataset (Figure
3A). In particular, only a small proportion of the total num-
ber of CGI-CpGs should be theoretically sequenced (102
253 out of 2 164 614), and this was indeed the case (Figure
3A). Furthermore, upon filtering out sites with low depth
of coverage, which commonly represent noise in RRBS
datasets, the sensitivity increased up to∼80%. Importantly,
the specificity remained constant at ∼100% independent of
the threshold set for depth of coverage (Figure 3B). Thus,
cuRRBS produces a prediction that is relatively conserva-
tive, as highlighted by the low numbers of false positives
(Figure 3A), at the expense of a small decrease in sensitivity.
Interestingly, the original theoretical size range that the
study was aiming for (110–200 bp) was slightly different to
the one achieved in the actual experiments (90–185 bp) (30).
We ran cuRRBS using the original size range target and
obtained slightly worse results for the sensitivity but not
the specificity of the prediction (Supplementary Figure S6A
and B). This demonstrates that the correct execution of the
size selection step during the experimental protocol is key
for obtaining the sites predicted by cuRRBS and highlights
the importance of the robustness variable as part of the cuR-
RBS output in order to judge the consequences of these ex-
perimental errors.
To test the accuracy of cuRRBS predictions in the con-
text of a double enzyme digestion, we utilised the non-
canonical RRBS dataset generated from mouse DNA us-
ing the restriction enzymes MspI and TaqI (31). To com-
pare the accuracy of cuRRBS prediction in this double en-
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Figure 3. Experimental validation of cuRRBS. (A) Barplots showing the number of true positives (TP, in green), true negatives (TN, in blue), false positives
(FP, in red) and false negatives (FN, in orange) when comparing cuRRBS theoretical prediction with the actual XmaI-RRBS experimental data (30). The
number of sites in each category is calculated for different thresholds in the depth of coverage (number of reads covering a CpG site as reported by Bismark).
cuRRBS prediction for the CpG sites in human CpG islands was obtained enforcing a theoretical size range of 90–185 bp and running the software for
XmaI with all the default parameters (with a read length of 200 bp). Legend is displayed on the right hand side. (B) Plot showing values of cuRRBS
sensitivity (in light green) and specificity (in cyan) as a function of the depth of coverage threshold employed to filter the experimental data (30). The
number of true positives (TP), true negatives (TN), false positives (FP) and false negatives (FN) are the same as in A. Legend is displayed below the plot
curves.
zyme system to that of the XmaI-RRBS system, we again
ran cuRRBS for CGI-CpGs, this time in the mouse genome
with a theoretical size range of 80–160 bp (31). cuRRBS
predicted with high accuracy the CpG sites that were ob-
served in this double enzyme experiment (Supplementary
Figure S6C). In addition, the results for sensitivity and
specificity were very similar to the ones reported for the
XmaI-RRBS dataset (Supplementary Figure S6D). There-
fore, we conclude that cuRRBS produces robust predictions
for the sites of interest that will be sequenced in RRBS pro-
tocols both for single and double enzyme combinations in-
dependent of the genome under study.
Lastly, the number of fragments that were theoretically
recoverable in each of our experimental systems ranged
from NF = 12 780 (for XmaI) to NF = 331 058 (for MspI
and TaqI). This represents approximately a 30-fold differ-
ence in the number of recoverable fragments and demon-
strates that cuRRBS predictions, even for low NF values,
are experimentally feasible. Importantly, in the nine theoret-
ical examples that we report (Supplementary Figure S4), the
number of fragments required by each cuRRBS protocol
ranges from 107 248 to 974 050. Thus, the number of frag-
ments required to achieve the stated CRF comfortably ex-
ceeds the minimum experimentally validatedNF value (>8-
fold).
CONCLUSIONS AND FUTURE DIRECTIONS
cuRRBS provides a new framework that allows the user to
optimiseRRBS for the biological systemof interest by using
novel combinations of restriction enzymes. Therefore, cuR-
RBS makes the study of DNAmethylation more affordable
across all species for which genomic sequences are available.
Furthermore, it can open the door to the design of future
studies in a clinical context (10), which require cost-effective
and robust protocols.
Currently, cuRRBS only considers combinations of up
to two restriction enzymes. However, in the future, it would
be possible to adapt the software to explore combinations
that contain higher numbers of enzymes, which could the-
oretically allow targeting the sites of interest even more ef-
ficiently (28). Moreover, there are several methods that are
able to impute DNA methylation levels in sites that are not
covered experimentally (46,60). These methods could ex-
pand the set of sites of interest that are finally measured by
making use of the additional DNA methylation informa-
tion that is retrieved in a cuRRBS experiment.
Finally, the potential of restriction enzymes to target dif-
ferent genomic coordinates is not limited to DNA methy-
lation. As such, it would be conceivable for cuRRBS to be
adapted to enrich for SNPs of interest (61,62) or to optimise
chromosome conformation capture techniques (63,64). By
reducing the cost associated with sequencing, we believe
that cuRRBS will help to democratise high-throughput ge-
nomic studies.
DATA AVAILABILITY
cuRRBS and its documentation are freely distributed under
GNU General Public License v3.0 and can be accessed via
GitHub (51). The publicRRBS data used in thismanuscript
can be found under GEO accession numbers GSE74126
(XmaI-RRBS) and GSE80961 (MspI&TaqI-RRBS) re-
spectively.
11568 Nucleic Acids Research, 2017, Vol. 45, No. 20
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENTS
We thank all the members of the Reik and Thornton lab-
oratories for helpful discussions. Specifically, we would like
to acknowledge Dr Dobril Ivanov for his very useful feed-
back and advice, Dr Courtney Hanna for providing the im-
printed loci, Dr Ines Milagre for facilitating the iPSC sites,
Dr Matthew T. Maurano for kindly providing the CTCF
peaks from methylation-sensitive binding sites, Dr Oliver
Stegle for his input regarding optimisation and Julia Spin-
del and Dr Aartjan te Velthuis for critically reviewing this
manuscript.
Authors’ contributions: D.E.M.H., J.M.T., W.R. and T.M.S.
designed the study. D.E.M.H. and T.M.S. designed and de-
veloped cuRRBS. A.J.M.R. implemented the last version
of cuRRBS. D.E.M.H. and T.M.S. conducted data analysis.
F.K. processed the RRBS datasets. D.E.M.H., J.M.T., W.R.
and T.M.S. interpreted data and wrote the manuscript. All
authors read and approved the final manuscript.
FUNDING
EMBL predoctoral fellowship [to D.E.M.H.]; EMBL
postdoctoral fellowship [to A.J.M.R.]; BBSRC DTP stu-
dentship [to T.M.S.]; Biotechnology and Biological Sci-
ences Research Council [BB/K010867/1 to W.R.]; Well-
come Trust [098565/Z/12/Z to J.M.T.; 095645/Z/11/Z
to W.R.]; EU BLUEPRINT [to W.R.]; EpiGeneSys [to
W.R.]. Funding for open access charge: Wellcome Trust
[098565/Z/12/Z].
Conflict of interest statement.W.R. is a consultant and
shareholder of Cambridge Epigenetix.
REFERENCES
1. Shendure,J. and Ji,H. (2008) Next-generation DNA sequencing. Nat.
Biotechnol., 26, 1135–1145.
2. Sierro,N., Battey,J.N.D., Ouadi,S., Bakaher,N., Bovet,L., Willig,A.,
Goepfert,S., Peitsch,M.C. and Ivanov,N.V. (2014) The tobacco
genome sequence and its comparison with those of tomato and
potato. Nat. Commun., 5, 3833.
3. Mouse Genome Sequencing Consortium, Waterston,R.H.,
Lindblad-Toh,K., Birney,E., Rogers,J., Abril,J.F., Agarwal,P.,
Agarwala,R., Ainscough,R., Alexandersson,M. et al. (2002) Initial
sequencing and comparative analysis of the mouse genome. Nature,
420, 520–562.
4. Lander,E.S., Linton,L.M., Birren,B., Nusbaum,C., Zody,M.C.,
Baldwin,J., Devon,K., Dewar,K., Doyle,M., FitzHugh,W. et al.
(2001) Initial sequencing and analysis of the human genome. Nature,
409, 860–921.
5. Fumagalli,M. (2013) Assessing the effect of sequencing depth and
sample size in population genetics inferences. PLoS ONE, 8, e79667.
6. Wu,H., Xu,T., Feng,H., Chen,L., Li,B., Yao,B., Qin,Z., Jin,P. and
Conneely,K.N. (2015) Detection of differentially methylated regions
from whole-genome bisulfite sequencing data without replicates.
Nucleic Acids Res., doi:10.1093/nar/gkv715.
7. Ziller,M.J., Gu,H., Mu¨ller,F., Donaghey,J., Tsai,L.T.Y.,
Kohlbacher,O., De Jager,P.L., Rosen,E.D., Bennett,D.A.,
Bernstein,B.E. et al. (2013) Charting a dynamic DNA methylation
landscape of the human genome. Nature, 500, 477–481.
8. Kirschner,S.A., Hunewald,O., Me´riaux,S.B., Brunnhoefer,R.,
Muller,C.P. and Turner,J.D. (2016) Focussing reduced representation
CpG sequencing through judicious restriction enzyme choice.
Genomics, 107, 109–119.
9. Yu,L., Liu,C., Bennett,K., Wu,Y.-Z., Dai,Z., Vandeusen,J.,
Opavsky,R., Raval,A., Trikha,P., Rodriguez,B. et al. (2004) A
NotI-EcoRV promoter library for studies of genetic and epigenetic
alterations in mouse models of human malignancies. Genomics, 84,
647–660.
10. Lee,Y.K., Jin,S., Duan,S., Lim,Y.C., Ng,D.P., Lin,X.M., Yeo,G.S.
and Ding,C. (2014) Improved reduced representation bisulfite
sequencing for epigenomic profiling of clinical samples. Biol. Proced.
Online, 16, 1.
11. Cedar,H., Solage,A., Glaser,G. and Razin,A. (1979) Direct detection
of methylated cytosine in DNA by use of the restriction enzyme
MspI. Nucleic Acids Res., 6, 2125–2132.
12. Karimi,M., Johansson,S. and Ekstro¨m,T.J. (2006) Using LUMA: a
Luminometric-based assay for global DNA-methylation. Epigenetics,
1, 45–48.
13. Guo,H., Zhu,P., Guo,F., Li,X., Wu,X., Fan,X., Wen,L. and Tang,F.
(2015) Profiling DNA methylome landscapes of mammalian cells
with single-cell reduced-representation bisulfite sequencing. Nat.
Protoc., 10, 645–659.
14. Hahn,M.A., Li,A.X., Wu,X. and Pfeifer,G.P. (2015) Single base
resolution analysis of 5-methylcytosine and 5-hydroxymethylcytosine
by RRBS and TAB-RRBS.Methods Mol. Biol., 1238, 273–287.
15. Li,D., Zhang,B., Xing,X. and Wang,T. (2015) Combining MeDIP-seq
and MRE-seq to investigate genome-wide CpG methylation.
Methods, 72, 29–40.
16. Cohen-Karni,D., Xu,D., Apone,L., Fomenkov,A., Sun,Z., Davis,P.J.,
Kinney,S.R.M., Yamada-Mabuchi,M., Xu,S.-Y., Davis,T. et al.
(2011) The MspJI family of modification-dependent restriction
endonucleases for epigenetic studies. Proc. Natl. Acad. Sci. U.S.A.,
108, 11040–11045.
17. Saliba,A.-E., Westermann,A.J., Gorski,S.A. and Vogel,J. (2014)
Single-cell RNA-seq: advances and future challenges. Nucleic Acids
Res., 42, 8845–8860.
18. Plongthongkum,N., Diep,D.H. and Zhang,K. (2014) Advances in the
profiling of DNA modifications: cytosine methylation and beyond.
Nature Publishing Group, 15, 647–661.
19. Frankhouser,D.E., Murphy,M., Blachly,J.S., Park,J., Zoller,M.W.,
Ganbat,J.-O., Curfman,J., Byrd,J.C., Lin,S., Marcucci,G. et al. (2014)
PrEMeR-CG: inferring nucleotide level DNA methylation values
from MethylCap-seq data. Bioinformatics, 30, 3567–3574.
20. Hughes,S. and Jones,J.L. (2007) The use of multiple displacement
amplified DNA as a control for methylation specific PCR,
pyrosequencing, bisulfite sequencing and methylation-sensitive
restriction enzyme PCR. BMCMol. Biol., 8, 91.
21. Komori,H.K., LaMere,S.A., Torkamani,A., Hart,G.T.,
Kotsopoulos,S., Warner,J., Samuels,M.L., Olson,J., Head,S.R.,
Ordoukhanian,P. et al. (2011) Application of microdroplet PCR for
large-scale targeted bisulfite sequencing. Genome Res., 21, 1738–1745.
22. Boyle,P., Clement,K., Gu,H., Smith,Z.D., Ziller,M., Fostel,J.L.,
Holmes,L., Meldrim,J., Kelley,F., Gnirke,A. et al. (2012) Gel-free
multiplexed reduced representation bisulfite sequencing for
large-scale DNA methylation profiling. Genome Biol., 13, R92.
23. Hodges,E., Smith,A.D., Kendall,J., Xuan,Z., Ravi,K., Rooks,M.,
Zhang,M.Q., Ye,K., Bhattacharjee,A., Brizuela,L. et al. (2009) High
definition profiling of mammalian DNA methylation by array capture
and single molecule bisulfite sequencing. Genome Res., 19, 1593–1605.
24. Huang,X., Lu,H., Wang,J.-W., Xu,L., Liu,S., Sun,J. and Gao,F.
(2013) High-throughput sequencing of methylated cytosine enriched
by modification-dependent restriction endonuclease MspJI. BMC
Genet., 14, 56.
25. Stevens,M., Cheng,J.B., Li,D., Xie,M., Hong,C., Maire,C.L.,
Ligon,K.L., Hirst,M., Marra,M.A., Costello,J.F. et al. (2013)
Estimating absolute methylation levels at single-CpG resolution from
methylation enrichment and restriction enzyme sequencing methods.
Genome Res., 23, 1541–1553.
26. Kurdyukov,S. and Bullock,M. (2016) DNA methylation analysis:
choosing the right method. Biology (Basel), 5, E3.
27. Suzuki,M. and Greally,J.M. (2013) Genome-wide DNA methylation
analysis using massively parallel sequencing technologies. Semin.
Hematol., 50, 70–77.
28. Bystrykh,L.V. (2013) A combinatorial approach to the restriction of a
mouse genome. BMC Res. Notes, 6, 284.
Nucleic Acids Research, 2017, Vol. 45, No. 20 11569
29. Meissner,A., Gnirke,A., Bell,G.W., Ramsahoye,B., Lander,E.S. and
Jaenisch,R. (2005) Reduced representation bisulfite sequencing for
comparative high-resolution DNA methylation analysis. Nucleic
Acids Res., 33, 5868–5877.
30. Tanas,A.S., Borisova,M.E., Kuznetsova,E.B., Rudenko,V.V.,
Karandasheva,K.O., Nemtsova,M.V., Izhevskaya,V.L.,
Simonova,O.A., Larin,S.S., Zaletaev,D.V. et al. (2017) Rapid and
affordable genome-wide bisulfite DNA sequencing by XmaI-reduced
representation bisulfite sequencing. Epigenomics,
doi:10.2217/epi-2017-0031.
31. Lim,Y.C., Chia,S.Y., Jin,S., Han,W., Ding,C. and Sun,L. (2016)
Dynamic DNA methylation landscape defines brown and white cell
specificity during adipogenesis.Mol. Metab., 5, 1033–1041.
32. Meissner,A., Mikkelsen,T.S., Gu,H., Wernig,M., Hanna,J.,
Sivachenko,A., Zhang,X., Bernstein,B.E., Nusbaum,C., Jaffe,D.B.
et al. (2008) Genome-scale DNA methylation maps of pluripotent
and differentiated cells. Nature, 454, 766–770.
33. Stubbs,T.M., Bonder,M.J., Stark,A.-K., Krueger,F. and BI Ageing
Clock TeamBI Ageing Clock Team, von Meyenn,F., Stegle,O. and
Reik,W. (2017) Multi-tissue DNA methylation age predictor in
mouse. Genome Biol., 18, 68.
34. Smith,Z.D., Gu,H., Bock,C., Gnirke,A. and Meissner,A. (2009)
High-throughput bisulfite sequencing in mammalian genomes.
Methods, 48, 226–232.
35. Hanna,C.W., Pen˜aherrera,M.S., Saadeh,H., Andrews,S.,
McFadden,D.E., Kelsey,G. and Robinson,W.P. (2016) Pervasive
polymorphic imprinted methylation in the human placenta. Genome
Res., 26, 756–767.
36. Milagre,I., Stubbs,T.M., King,M.R., Spindel,J., Santos,F.,
Krueger,F., Bachman,M., Segonds-Pichon,A., Balasubramanian,S.,
Andrews,S.R. et al. (2017) Gender differences in global but not
targeted demethylation in iPSC reprogramming. Cell Rep., 18,
1079–1089.
37. Horvath,S. (2013) DNA methylation age of human tissues and cell
types. Genome Biol., 14, R115.
38. Kawakatsu,T., Huang,S.-S.C., Jupe,F., Sasaki,E., Schmitz,R.J.,
Urich,M.A., Castanon,R., Nery,J.R., Barragan,C., He,Y. et al. (2016)
Epigenomic diversity in a global collection of Arabidopsis thaliana
accessions. Cell, 166, 492–505.
39. Maurano,M.T., Wang,H., John,S., Shafer,A., Canfield,T., Lee,K. and
Stamatoyannopoulos,J.A. (2015) Role of DNA methylation in
modulating transcription factor occupancy. Cell Rep., 12, 1184–1195.
40. Lev Maor,G., Yearim,A. and Ast,G. (2015) The alternative role of
DNA methylation in splicing regulation. Trends Genet., 31, 274–280.
41. Domcke,S., Bardet,A.F., Adrian Ginno,P., Hartl,D., Burger,L. and
Schu¨beler,D. (2015) Competition between DNA methylation and
transcription factors determines binding of NRF1. Nature, 528,
575–579.
42. Roberts,R.J., Vincze,T., Posfai,J. and Macelis,D. (2015) REBASE–a
database for DNA restriction and modification: enzymes, genes and
genomes. Nucleic Acids Res., 43, D298–D299.
43. Roberts,R.J., Vincze,T., Posfai,J. and Macelis,D. (2005)
REBASE–restriction enzymes and DNA methyltransferases. Nucleic
Acids Res., 33, D230–D232.
44. Harrow,J., Frankish,A., Gonzalez,J.M., Tapanari,E., Diekhans,M.,
Kokocinski,F., Aken,B.L., Barrell,D., Zadissa,A., Searle,S. et al.
(2012) GENCODE: the reference human genome annotation for The
ENCODE Project. Genome Res., 22, 1760–1774.
45. Bock,C., Walter,J., Paulsen,M. and Lengauer,T. (2007) CpG island
mapping by epigenome prediction. PLoS Comput. Biol., 3, e110.
46. Zhang,W., Spector,T.D., Deloukas,P., Bell,J.T. and Engelhardt,B.E.
(2015) Predicting genome-wide DNA methylation using methylation
marks, genomic position, and DNA regulatory elements. Genome
Biol., 16, 14.
47. Taher,L., Smith,R.P., Kim,M.J., Ahituv,N. and Ovcharenko,I. (2013)
Sequence signatures extracted from proximal promoters can be used
to predict distal enhancers. Genome Biol., 14, R117.
48. Dale,R.K., Pedersen,B.S. and Quinlan,A.R. (2011) Pybedtools: a
flexible Python library for manipulating genomic datasets and
annotations. Bioinformatics, 27, 3423–3424.
49. Quinlan,A.R. and Hall,I.M. (2010) BEDTools: a flexible suite of
utilities for comparing genomic features. Bioinformatics, 26, 841–842.
50. Cock,P.J.A., Antao,T., Chang,J.T., Chapman,B.A., Cox,C.J.,
Dalke,A., Friedberg,I., Hamelryck,T., Kauff,F., Wilczynski,B. et al.
(2009) Biopython: freely available Python tools for computational
molecular biology and bioinformatics. Bioinformatics, 25, 1422–1423.
51. Martin-Herranz,D.E., Ribeiro,A.J.M. and Stubbs,T.M. (2017)
demh/cuRRBS: cuRRBS v1.0.4., doi:10.5281/zenodo.853452.
52. Kuhn,R.M., Haussler,D. and Kent,W.J. (2013) The UCSC genome
browser and associated tools. Brief. Bioinformatics, 14, 144–161.
53. Mathelier,A., Fornes,O., Arenillas,D.J., Chen,C.-Y., Denay,G., Lee,J.,
Shi,W., Shyr,C., Tan,G., Worsley-Hunt,R. et al. (2016) JASPAR 2016:
a major expansion and update of the open-access database of
transcription factor binding profiles. Nucleic Acids Res., 44,
D110–D115.
54. Bardet,A.F., Steinmann,J., Bafna,S., Knoblich,J.A., Zeitlinger,J. and
Stark,A. (2013) Identification of transcription factor binding sites
from ChIP-seq data at high resolution. Bioinformatics, 29, 2705–2713.
55. Krueger,F. and Andrews,S.R. (2011) Bismark: a flexible aligner and
methylation caller for Bisulfite-Seq applications. Bioinformatics, 27,
1571–1572.
56. Wang,J., Xia,Y., Li,L., Gong,D., Yao,Y., Luo,H., Lu,H., Yi,N.,
Wu,H., Zhang,X. et al. (2013) Double restriction-enzyme digestion
improves the coverage and accuracy of genome-wide CpG
methylation profiling by reduced representation bisulfite sequencing.
BMC Genomics, 14, 11.
57. Martinez-Arguelles,D.B., Lee,S. and Papadopoulos,V. (2014) In silico
analysis identifies novel restriction enzyme combinations that expand
reduced representation bisulfite sequencing CpG coverage. BMC Res.
Notes, 7, 534.
58. Stroud,H., Do,T., Du,J., Zhong,X., Feng,S., Johnson,L., Patel,D.J.
and Jacobsen,S.E. (2014) Non-CG methylation patterns shape the
epigenetic landscape in Arabidopsis. Nat. Struct. Mol. Biol., 21,
64–72.
59. Sun,Y., Hou,R., Fu,X., Sun,C., Wang,S., Wang,C., Li,N., Zhang,L.
and Bao,Z. (2014) Genome-wide analysis of DNA methylation in five
tissues of Zhikong scallop, Chlamys farreri. PLoS ONE, 9, e86232.
60. Angermueller,C., Lee,H.J., Reik,W. and Stegle,O. (2017) DeepCpG:
accurate prediction of single-cell DNA methylation states using deep
learning. Genome Biol., 18, 67.
61. Davey,J.W., Davey,J.L., Blaxter,M.L. and Blaxter,M.W. (2010)
RADSeq: next-generation population genetics. Brief. Funct.
Genomics, 9, 416–423.
62. Davey,J.W., Hohenlohe,P.A., Etter,P.D., Boone,J.Q., Catchen,J.M.
and Blaxter,M.L. (2011) Genome-wide genetic marker discovery and
genotyping using next-generation sequencing. Nature Publishing
Group, 12, 499–510.
63. Naumova,N., Smith,E.M., Zhan,Y. and Dekker,J. (2012) Analysis of
long-range chromatin interactions using Chromosome Conformation
Capture.Methods, 58, 192–203.
64. Dekker,J., Marti-Renom,M.A. and Mirny,L.A. (2013) Exploring the
three-dimensional organization of genomes: interpreting chromatin
interaction data. Nature Publishing Group, 14, 390–403.
